Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin
Authors:
- 1 September 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 22 (3) , 371-375
Abstract
Two open studies of oral treatment of peritonitis in CAPD patients with ofloxacin are described. The first study included 10 episodes of peritonitis treated with ofloxacin 400 mg followed by 200 mg daily for a total of seven days. In the second study of 18 peritonitis episodes, the treatment was ofloxacin 400 mg followed by 300 mg daily for a total of ten days. The cure rate was 50% in the first study and 83% in the second. There was significant accumulation of ofloxacin in the serum but the mean serum trough level with the second treatment regimen platcaued at 6 mg/l on day 10. Peritoneal effluent ofloxacin levels correlated well with the prevailing serum concentrations of the antibiotic and, except on day 1, the mean peritoneal effluent ofloxacm levels all exceeded 3 mg/l with the second dosing scheme. Side effects were mainly nausea and dizziness.Keywords
This publication has 7 references indexed in Scilit:
- Ciprofloxacin in plasma and peritoneal dialysate after oral therapy in patients on continuous ambulatory peritoneal dialysisJournal of Antimicrobial Chemotherapy, 1987
- Continuous ambulatory peritoneal dialysis (CAPD): Experience with the first 100 patients in a Hong Kong CentreThe International Journal of Artificial Organs, 1987
- Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysisAntimicrobial Agents and Chemotherapy, 1986
- ORAL TREATMENT OF PERITONITIS COMPLICATING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS1985
- Multiple-dose ciprofloxacin kinetics in normal subjectsClinical Pharmacology & Therapeutics, 1984
- In vitro and in vivo activity of DL-8280, a new oxazine derivativeAntimicrobial Agents and Chemotherapy, 1982
- THREE YEARS' EXPERIENCE OF CONTINUOUS AMBULATORY PERITONEAL DIALYSISThe Lancet, 1981